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Introduction. Enterovirus (EV) and parechovirus (PeV) can 
either infect humans asymptomatically or can cause gastroenteri-
tis, respiratory symptoms and, sometimes, severe disease. As the 
number of newly identified EV and PeV genotypes keeps increas-
ing, diagnostic methods need to be updated. To this end, we 
described a novel multiplex one-step real-time RT-PCR to detect 
EV and human PeV (HPeV) simultaneously in fecal samples col-
lected from children with rotavirus group A (RV-A)-related gas-
troenteritis.
Methods. The specificity and sensitivity of the EV/HPeV real-
time RT-PCR were evaluated with two 2011 Quality Control for 
Molecular Diagnostics (QCMD) panels for EV and HPeV detec-
tion. RNA was extracted from 111 RV-A-positive fecal samples 
collected from children up to 5 years of age who had been hospi-
talized for gastroenteritis from September 2010 to August 2011.  
Results. The EV/HPeV real-time RT-PCR showed a 100% sen-
sitivity and specificity for EV and 91% and 91.7% for HPeV, 
respectively. Of the 111 RV-A-positive stool specimens, 28 
(25.2%) were EV-positive and 7 (6.3%) were HPeV-positive. No 
clinical differences between children with single or double infec-
tions were observed.
Discussion. In our study, the frequency of EV and HPeV infec-
tions was surprisingly high, thus underlining the importance of 
including EV and HPeV detection in diagnostic panels. The mul-
tiplex real-time RT-PCR presented in this paper can therefore be 
a useful method in a diagnostic setting.
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Summary
Introduction
The Picornaviridae family currently consists of 46 spe-
cies grouped into 26 genera [1]. Three of these genera 
include human pathogens: Enterovirus (EV), Hepatovi-
rus (hepatitis A virus), and Parechovirus (PeV). EVs and 
human PeVs (HPeV) may be associated with gastroen-
teritis as well as upper and lower respiratory tract infec-
tions [2-4], and can be detected in fecal and respiratory 
samples  [5-7]. Both viruses have tropism for neuronal 
cells, therefore implying their involvement in aseptic 
meningitis, encephalitis, encephalomyelitis [3, 8] and 
white matter abnormalities [9, 10].
In the last few years, advances in metagenomics and 
molecular biology have enabled the in-depth analysis 
of picornaviruses, the discovery of new EV and PeV 
genotypes, as well as a continuous update of their tax-
onomy [11]. The enterovirus genus now consists of 12 
species and contains more than 100 genotypes: human 
EVs (A-D), non-human EVs (E-H and J), and rhinovi-
ruses A-C - the most recently categorized within the EV 
genus  [12]. The parechovirus genus consists of two spe-
cies: zoonotic Ljungan virus and HPeV, the latter con-
taining 16 genotypes  [1]. As the number of genotypes 
increases, their molecular detection methods need to be 
updated in order to ensure high sensitivity and specific-
ity, particularly in a diagnostic setting.
This paper presents the novel multiplex one-step real-
time RT-PCR assay for the simultaneous detection of 
EV and HPeV for clinical fecal samples collected from 
hospitalized children with acute gastroenteritis in Lom-
bardy (northern Italy) from September 2010 to August 
2011.
Methods 
Multiplex one-step real-time RT-PCR assay
The assay was performed by using the following prim-
er/probe sets: 5’-GGTGCAAGAGTCTATTGAGC-3’ 
(EV-08 forward), 5’-CACCCAAGTAGTCG-
GTTCC-3’ (EV-08 reverse), and 5’-CCGGCCC-
CTGAATG-3’ (EV-probe) specific for the 5’non-
translated region (5’-NTR) (nt. 415-555) of EVs, 
as published by Nielsen et al.  [13]; 5’-GTAACAS-
WWGCCTCTGGGSCCAAAAG-3’ (AN345-for-
ward), 5’-GGCCCCWGRTCAGATCCAYAGT-3’ 
(AN344-reverse), and 5’-CCTRYGGGTACCTYCW-
GGGCATCCTTC-3’ (AN257-probe) specific for the 
5’-NTR (nt. 421-615) of HPeVs as published by Nix et 
al. [14]. The following two fluorescent dyes were used: 
6-FAM for the EV-probe and VIC for the HPeV-probe. 
BHQ1 quencher was used for both probes.
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The multiplex one-step real-time RT-PCR for EV and 
HPeV detection was prepared with 5 μl of RNA in a total 
volume of 25 μl with the AgPath-ID One-Step RT-PCR 
kit (Ambion®, Life Technologies, USA). The reaction 
mixture contained 1 µM of each EV primer, 0.4 µM of 
each HPeV primer and 0.2 µM of each probe and was 
carried out in a 7300 Real-time PCR System (Applied 
Biosystem®, Life Technologies, USA) with the follow-
ing thermal profile: 50 °C × 30 min, 95 °C × 15 min, and 
50 cycles at 95 °C × 15 sec, 58 °C × 30 sec, and 72 °C 
× 10 sec. 
Sensitivity and specificity of the multiplex 
one-step real-time RT-PCR
The sensitivity and specificity of the multiplex one-
step real-time RT-PCR were evaluated with two Qual-
ity Control for Molecular Diagnostics (QCMD) panels 
[15]: the QCMD 2011 Enterovirus RNA EQA Pro-
gramme (2011 EV-QCMD), and the QCMD 2011 Pare-
chovirus RNA EQA Programme (2011 PeV-QCMD). 
The 2011 EV–QCMD panel consisted of 12 samples: 10 
were EV-positive (Coxsackievirus A16, A21, and A24; 
EV68; EV71; Echovirus 11 and 30; stock dilutions: 10-3-
10-7), one contained human Rhinovirus 16, and one was 
viral transport medium (VTM). The 2011 PeV-QCMD 
panel consisted of 11 samples: 8 were HPeV-positive 
(HPeV 1-5; stock dilutions: 10-3-10-7), one contained hu-
man Rhinovirus 16, one contained Coxsackievirus A21, 
and one was VTM. 
The inter- and intra-assay variation of the one-step real-
time RT-PCR were calculated and expressed by coef-
ficient of variation (%CV). 
Clinical fecal specimens 
From September 2010 to August 2011, fecal samples 
were collected from children aged 0-5 years old (62.2% 
males, median age: 12 months; inter-quartile range 
[IQR]: 12 months) who had been hospitalized for acute 
rotavirus-A related (RV-A) gastroenteritis, in Lombardy 
(northern Italy). Rotavirus infection was diagnosed on 
admission to hospital by commercial routine immuno-
chromatographic or latex-agglutination tests. Overall, in 
this study, 111 RV-A-positive fecal samples were ana-
lyzed anonymously by the multiplex one-step real-time 
RT-PCR method described previously.
At the time of hospitalization, all children presented 
with clinical signs of gastroenteritis, i.e. fever and/or 
abdominal pain and/or diarrhea and/or vomiting. Diar-
rhea was the most frequently reported symptom (88/111: 
79.3%), followed by vomiting (78/111: 70.3%) and fe-
ver (67/111: 60.4%). Abdominal pain was detected in 38 
cases (34.2%) and only in association with one or more 
symptoms. The majority of children (84/111: 75.7%) 
presented with more than one gastroenteritis sign and all 
symptoms were present in 20.6% (23/111) of children 
studied. 
RNA was extracted for testing with the commercial 
kit Invisorb® Spin Virus RNA Mini kit, (Stratec Mo-
lecular, Germany). To monitor RNA extraction each 
clinical sample was tested for the presence of human 
RNase P gene (RNP) by using a specific primer/probe 
set (TaqMan® RNase P Assay, ABY® dye/QSY® probe, 
Life Technologies, USA). Five µl of each sample’s 
RNA were added to a reaction mixture that consisted 
of 12.5 µl AgPath-ID One-Step RT-PCR kit (Ambion®, 
Life Technologies, USA), 0.4 µM of each RNase P 
primer, 0.2 µM of probe and biological grade water up 
to 20 µl. The reaction was carried out at the same con-
ditions of the multiplex one-step real-time RT-PCR, as 
described above. Each sample should exhibit RNP re-
action curves that cross the threshold line at or before 
40 cycle threshold (CT). A sample was considered posi-
tive to EV/HPeV when a curve crosses the threshold 
before or at 40 CT. 
Results
Sensitivity and specificity of the multiplex 
one-step real-time RT-PCR assay
The EV/HPeV real-time RT-PCR assay presented in 
this study detected all EV-positive samples included 
in the 2011 EV-QCMD and 2011 PeV-QCMD panels 
(sensitivity: 100%). The assay detected all EV-dilu-
tions until the least concentrated (limit of detection: 
10-7), which were identified by 55.4% of all laborato-
ries participating in the 2011 EV-QCMD programme. 
Therefore, the EV/HPeV real-time RT-PCR detected 
all EV species included in 2011 EV- and PeV-QCMD 
panels and no cross-reactions were observed with the 
rhinoviruses included in the panels: the assay specific-
ity was 100%.
Our multiplex assay identified all HPeV-positive speci-
mens included in the 2011 PeV-QCMD panel except the 
PeV3 10-7 stock dilution, which was detected success-
fully only by 24.1% of all participants in the 2011 PeV-
QCMD programme. The limit of detection for HPeV 
was 10-6 and the assay sensitivity was 91%. The speci-
ficity of the multiplex was 91.7% for HPeV, because a 
cross-reaction between HPeV and Coxsackievirus A16 
was identified. A singleplex assay for HPeV was set up 
with the same conditions as the multiplex assay and no 
differences in sensitivity and specificity were observed. 
No differences in terms of CT values (mean standard de-
viation: 0.97 for EV and 0.59 for HPeV) were observed 
when mixes of EV and HPeV concentrations were used. 
The intra-assay %CVs of the real-time RT-PCR assay 
were 0.99% and 2.09% for EV and HPeV, respectively. 
The inter-assay %CV was 4.1% for EV and 3.9% for 
HPeV. 
EV and HPeV detection in clinical fecal 
specimens
During the 12-month study period, 111 RV-A-positive 
stool samples were collected and analyzed with the mul-
tiplex assay. Twenty-eight (28/111: 25.2%) were posi-
tive for EV and 7 (7/111: 6.3%) for HPeV. No triple 
infections (EV/HPeV/RV-A) were detected. 
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The median CT values of EV-positive samples was 34.31 
(IQR: 2.70; range: 18.22-39.75); the median CT values 
of HPeV-positive samples was 36.66 (IQR: 1.01; range: 
28.25-39.02). 
Figure 1 displays the monthly trend of RV-A-positive 
specimens with the detection of EV and HPeV. The 
occurrence of RV-A infections peaked in late winter/
beginning of spring (March 2011). RV-A/EV co-infec-
tions were found throughout the year, especially (10/28: 
35.7%) during springtime (March-April 2011). RV-A/
HPeV co-infections were observed from February to 
April and in July 2011. 
In our study, the mean age of children with co-infec-
tion was 19 months for RV-A/EV (range: 26 days – 60 
months; median age: 12 months; IQR: 12 months) and 
23.3 months for RV-A/HPeV (range: 5 – 48 months; 
median age: 24 months; IQR: 6 months). However, no 
significant differences (p-value>0.05) were found be-
tween the two groups. In addition, patients with a double 
infection did not show more severe clinical symptoms. 
Discussion
As the number of novel picornaviruses identified over 
the last few years increases considerably, the continuous 
validation and update of existing EV and HPeV assays 
is essential.
We set up a multiplex one-step real-time RT-PCR as-
say combining the EV assay by Nielsen et al. [13] and 
the HPeV assay by Nix et al. [14]. The sensitivity and 
the specificity of the EV/HPeV real-time RT-PCR were 
tested on two 2011 EV/PeV QCMD panels and result-
ed with 100% for EV and 91% and 91.7% for HPeV, 
respectively. Contrary to another study [16], it is note-
worthy that no cross-reactions between EVs and other 
viruses, such as rhinoviruses, were observed here.
Viral intestinal infections are the most common cause of 
acute infectious diarrhea in children [17]. Over the past 
decade, there have been major advances in the under-
standing of viral gastroenteritis etiology. Group A ro-
tavirus is responsible for the majority of acute diarrhea 
in young children worldwide  [18]. Furthermore, other 
viruses like norovirus, adenovirus, enterovirus, bocavi-
rus, sapovirus, astrovirus, calicivirus, and, more recent-
ly, torovirus and parechovirus have also been identified 
thanks to the development of rapid molecular tech-
niques [18, 19]. The frequencies of EV (about 25%) and 
HPeV (about 6%) infections observed in our study were 
much higher than those reported by Rovida et al. [20], 
who showed the frequencies of EV and HPeV infections 
in pediatric and adult populations with gastroenteritis to 
be 3% and 1%, respectively. Several studies have evalu-
ated the clinical impact of mixed infections believed to 
be the cause of severe diarrhea in children under 5, and 
they have found that the frequencies of mixed infections 
fluctuate between 5% and 34% [19-23]. It is difficult to 
compare such findings as dual infections are often mis-
diagnosed or not investigated at all in routine laboratory 
work. For example, Rimoldi et al. [24] only included EV 
in their viral gastroenteritis panel and no samples were 
EV-positive, whereas HPeV was not considered at all.
Fig. 1. Number of positive samples for ev, hpev and rv–A in children ≤5 years hospitalized with gastroenteritis from September 2010 to 
August 2011.
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Conclusions
The impact of EV and HPeV on childhood gastroenteri-
tis is still unknown due to the lack of systematic testing 
of clinical samples. In our study, the high frequency of 
both EV and HPeV in clinical fecal samples underlines 
the importance of introducing EV and HPeV assays in 
routine laboratory practice. 
A fast, sensitive and specific test, such as the EV/HPeV 
multiplex real-time RT-PCR described above, is a useful 
tool for the detection of these viruses in fecal samples as 
well as in other clinical samples.
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